Allucent Names Paula Brown Stafford as CEO Industry Veteran to Lead Next Phase of Global CRO’s Expansion

Jul 24, 2024

Posted by Allucent

Introducing RushMab® – Gene, 100ug transfection-grade expression plasmids ready in 4 DAYS!

Jul 16, 2024

Posted by Biointron Biological

Biointron’s Q2 2024 Antibody Industry Report is OUT NOW!

Jul 16, 2024

Posted by Biointron Biological

Upperton Pharma Solutions Adds Large-Scale Processing Following MHRA Approval at Nottingham Facility.

Jul 15, 2024

Posted by Upperton

RENTSCHLER BIOPHARMA ANNOUNCES NEW STATE-OF-THE-ART PRODUCTION LINE IN MASSACHUSETTS IS FULLY OPERATIONAL!

Jul 11, 2024

Posted by Rentschler Biopharma Inc

Allucent Awarded 5-Year BARDA Agreement Aimed at Enhancing and Accelerating Decentralized Clinical Trials for Medical Countermeasure Development

Jul 11, 2024

Posted by Allucent